Menu
Recruiting NCT04489238

Collection of Information to Better Understand Young Onset Colorectal Cancer

Observational Colorectal Cancer Colorectal Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Risk Factor Questionnaire.
Who it may be relevant to
Registry conditions: Colorectal Cancer, Colorectal Carcinoma. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Young Onset Gastrointestinal Cancer Prospective Registry

Overview

The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.

Interventions

  • Other Risk Factor Questionnaire
    Participants, both cases and controls, will complete the CYOC risk factor questionnaire, preferably at the time of first visit

Primary outcome measures

  • Establish a prospective database of patients with Young Onset Colorectal Cancer [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

Participant Inclusion Criteria for database and questionnaire (YOGI)

  • Histological or cytological diagnosis of gastrointestinal cancer
  • 18 - 49 years old at time of consent
  • No Known hereditary CRC or other cancer predisposition syndrome (stool collection cohort only)
  • No history of inflammatory bowel disease (stool collection cohort only)
  • No prior diagnosis of gastrointestinal cancer (stool collection cohort only)

Participant Inclusion Criteria for database and questionnaire (Controls)

  • Histological or cytological diagnosis of colorectal adenocarcinoma
  • No previous treatment for CRC (including surgery, chemotherapy, immunotherapy or radiation)
  • Age 50 or older at time of consent
  • No Known hereditary CRC or other cancer predisposition syndrome
  • No history of inflammatory bowel disease
  • No prior diagnosis of CRC

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

United States · 8 centers
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge
  • Memorial Sloan Kettering Monmouth — Middletown
  • Memorial Sloan Kettering Bergen — Montvale
  • Memorial Sloan Kettering Cancer Center @ Commack — Commack
  • Memorial Sloan Kettering Westchester — Harrison
  • MSK at Ralph Lauren — New York
  • Memorial Sloan Kettering Cancer Center — New York
  • Memorial Sloan Kettering Nassau — Rockville Centre

Identifiers

NCT: NCT04489238 · 20-315

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗